RNAi Roundtable: ALN-CC5 for the treatment of Complement-Mediated Diseases

RNAi Roundtable: ALN-CC5 for the treatment of Complement-Mediated Diseases

On July 23, 2015, we hosted an online RNAi Roundtable to review the progress with ALN-CC5 in development for the treatment of Complement-Mediated Diseases.

View the presentation
Read the transcript



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.